PGE2 in Pancreatic Cyst Fluid Helps Differentiate IPMN from MCN and Predict IPMN Dysplasia

[1]  S. Gourgiotis,et al.  Intraductal papillary mucinous neoplasms of the pancreas. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  K. Lillemoe,et al.  IPMN—Controversies in an “Epidemic” , 2006, Journal of surgical oncology.

[3]  C. Schmidt,et al.  Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia. , 2006, Neoplasia.

[4]  S. Chari,et al.  International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.

[5]  K. Campbell,et al.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience , 2004, Annals of surgery.

[6]  C. Bassi,et al.  Main-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: Clinical Predictors of Malignancy and Long-term Survival Following Resection , 2004, Annals of surgery.

[7]  H. Pitt,et al.  Cystic Pancreatic Neoplasms: Observe or Operate , 2004, Annals of surgery.

[8]  M. D'Angelica,et al.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Analysis of Clinicopathologic Features and Outcome , 2004, Annals of surgery.

[9]  O. Cummings,et al.  Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. , 2003, Archives of surgery.

[10]  B. Petersen,et al.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. , 2002, Gastroenterology.

[11]  D. Klimstra,et al.  Intraductal papillary‐mucinous neoplasms of the pancreas , 2002, Cancer.

[12]  K. Lillemoe,et al.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Increasingly Recognized Clinicopathologic Entity , 2001, Annals of surgery.